Plandai Biotechnology Total Liabilities

Plandai Biotechnology (PLPL) currently reports a total liabilities of $160K as of September 2024. That compares with $450K in the prior-year period — down 65.0% year over year. Use the charts on this page to explore Plandai Biotechnology's total liabilities history and peer comparisons.

Plandai Biotechnology's total liabilities decreased from $450K to $160K — a 65.0% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Plandai Biotechnology reported $160K in total liabilities as of September 2024. That compares with $450K in the prior-year period — down 65.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $160K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Plandai Biotechnology, and consider following PLPL for alerts when major investors trade the stock.

Plandai Biotechnology is classified in the Healthcare sector. On total liabilities, it currently shows $160K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PLPL with unrelated industries.